Pfizer Inc. is pleased to announce that the FDA has approved TALZENNA®

Pfizer Inc. is pleased to announce that the FDA has approved TALZENNA® (talazoparib) for a new indication. The following information is for State Society review:

• Please see full Prescribing Information for TALZENNA® (talazoparib).